Bezmialem Vakif University, Department of Internal Medicine, Fatih, Istanbul, Turkey.
Bezmialem Vakif University, Department of Nephrology, Fatih, Istanbul, Turkey.
Biomed Pharmacother. 2017 May;89:1409-1414. doi: 10.1016/j.biopha.2017.03.019. Epub 2017 Mar 19.
Amikacin has the largest spectrum among aminoglycosides, its nephrotoxic effect limits its utilization. Our purpose in this study is to review the protective effect of dexpanthenol against the nephrotoxic effect of amikacin, accompanied with histopathological and biochemical parameters.
32 rats were randomly separated into four groups with eight in each (amikacin (1.2mg/kg/day), amikacin (1.2mg/kg/day)+dexpanthenol (500mg/kg/day), dexpanthenol (500mg/kg/day) and control). In order to assess the oxidative balance and renal damage between groups, biochemical parameters (total antioxidant capacity (TAS), total oxidant stress (TOS), catalase (CAT), paraoxonase (PON), arylesterase (ARES), urea, and creatinin) were studied from the blood samples. At the end of the 14th day, renal tissues were reviewed blindly by a pathologist.
TOS and oxidative stress index (OSI) values were significantly lower in the group which was administered with dexpanthenol+amikacin compared to the group which only received amikacin (respectively, p=0.001, p=0.002). Antioxidant biochemical parameters (TAS, CAT, PON, and ARES) were significantly higher in the group which was administered with dexpanthenol+amikacin compared to the group administered only with amikacin (respectively, p=0.007, p=0.001, p=0.003, p=0.003). Urea and creatitin values were found to be significantly lower in the group which was administered with dexpanthenol+amikacin compared to the group administered only with amikacin (respectively, p=0.002, p=0.001). Histopathologic changes such as glomerular and tubular epithelium changes and interstitial edema were clearly observed in the group administered only with amikacin, such findings were insignificant in the group administered with dexpanthenol+amikacin.
It was revealed with biochemical and histopathologic data that nephrotoxic effects created by amikacin administration can be limited with dexpanthenol by using them together, and further advanced clinical studies are required.
阿米卡星在氨基糖苷类药物中具有最广的谱,其肾毒性作用限制了其应用。我们在这项研究中的目的是回顾二羟丙茶碱对阿米卡星肾毒性的保护作用,同时结合组织病理学和生化参数。
32 只大鼠随机分为四组,每组 8 只(阿米卡星(1.2mg/kg/天)、阿米卡星(1.2mg/kg/天)+二羟丙茶碱(500mg/kg/天)、二羟丙茶碱(500mg/kg/天)和对照组)。为了评估各组之间的氧化平衡和肾损伤,从血液样本中研究了生化参数(总抗氧化能力(TAS)、总氧化应激(TOS)、过氧化氢酶(CAT)、对氧磷酶(PON)、芳基酯酶(ARES)、尿素和肌酐)。在第 14 天结束时,由病理学家对肾脏组织进行盲法检查。
与仅接受阿米卡星的组相比,同时接受二羟丙茶碱+阿米卡星的组 TOS 和氧化应激指数(OSI)值显著降低(分别为 p=0.001,p=0.002)。同时接受二羟丙茶碱+阿米卡星的组的抗氧化生化参数(TAS、CAT、PON 和 ARES)明显高于仅接受阿米卡星的组(分别为 p=0.007,p=0.001,p=0.003,p=0.003)。与仅接受阿米卡星的组相比,同时接受二羟丙茶碱+阿米卡星的组的尿素和肌酐值明显降低(分别为 p=0.002,p=0.001)。仅接受阿米卡星的组观察到肾小球和肾小管上皮变化以及间质水肿等组织病理学变化,而同时接受二羟丙茶碱+阿米卡星的组则无明显变化。
生化和组织病理学数据显示,阿米卡星给药引起的肾毒性作用可以通过联合使用二羟丙茶碱来限制,需要进一步进行高级的临床研究。